Facebook
Linkedin
Tumblr
Twitter
Sign in
My Account
orders
Sign in
Welcome!
Log into your account
your username
your password
Forgot your password?
Password recovery
Recover your password
your email
Search
Sign in / Join
Facebook
Linkedin
Tumblr
Twitter
Sign in
Welcome! Log into your account
your username
your password
Forgot your password? Get help
Password recovery
Recover your password
your email
A password will be e-mailed to you.
Market Exclusive
My Account
orders
Home
Tags
NASDAQ:GILD
Tag: NASDAQ:GILD
Gilead Sciences, Inc. (NASDAQ:GILD) EPCLUSA Access To Be Provided In Ontario...
-
February 23, 2017
0
Gilead Sciences, Inc. (NASDAQ:GILD), GlaxoSmithKline Plc (NYSE:GSK) Battle Head-On In HIV...
Andy Parker
-
February 10, 2017
0
Celgene Corporation (NASDAQ:CELG) Eyes Expansion in 2017
-
January 25, 2017
0
Losses And Gains For Gilead Sciences, Inc. (NASDAQ:GILD) Under President Trump...
Andy Parker
-
January 23, 2017
0
Federal Judge Orders State Provide Mumia Abu-Jamal With HCV Treatment by...
-
January 5, 2017
0
GlaxoSmithKline Plc (NYSE:GSK) Phase 3 Trials Looks Positive: Will Gilead Endure?
Andy Parker
-
December 21, 2016
0
AbbVie Inc (NYSE:ABBV) Awaits NDA Approval For Hepatitis C Treatment
Andy Parker
-
December 21, 2016
0
Novartis AG (NYSE:NVS) Agrees To $50 Million Deal With Conatus Pharmaceuticals...
-
December 20, 2016
0
Gilead Sciences, Inc. (NASDAQ:GILD) Begins A Process That Could Alleviate Its...
-
December 1, 2016
0
Gilead Sciences, Inc. (NASDAQ:GILD) Takes Lead Against AbbVie Inc (NYSE:ABBV) On...
-
November 29, 2016
0
1
...
4
5
6
7
Page 5 of 7
